142 filings
Page 5 of 8
8-K
lnrbhbhrgfellsdhl
18 Jun 20
Departure of Directors or Certain Officers
4:16pm
8-K
lt3sshdtrw 56871y8
9 Jun 20
Material Modifications to Rights of Security Holders
4:06pm
8-K
rjl exg0xqayf
12 May 20
Other Events
4:18pm
8-K
j2om1vqi5 uvm
5 May 20
Akebia Announced PositiveTop-Line Results from Global Phase 3 Program of Vadadustat
8:22am
8-K
xsh9nny0z 0r9bm
20 Apr 20
Other Events
8:58am
8-K
dvw0em1dld6buhlxrp
8 Apr 20
Entry into a Material Definitive Agreement
4:44pm
8-K
t3iv2y5n
7 Apr 20
Departure of Directors or Certain Officers
8:12am
8-K
zmsiud
12 Mar 20
Other Events
4:58pm
8-K
nvvy owkp
10 Mar 20
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Hosts Conference Call to Discuss Recent Business Highlights
8:08am
8-K
osw5eidcnrfe3j
18 Feb 20
Other Events
7:00am
8-K
2b5tr85a8m1bld7wz6
12 Nov 19
Entry into a Material Definitive Agreement
5:20pm
8-K
j73n4
12 Nov 19
Akebia Secures $100 MillionNon-Dilutive Term Loan Financing; Reports Third Quarter 2019 Financial Results
8:59am
8-K
ke43pm0
11 Sep 19
Entry into a Material Definitive Agreement
4:15pm
8-K
6sztkb948lc6gsufngvo
8 Aug 19
Akebia Therapeutics Reports Second Quarter 2019 Financial Results and Hosts Conference Call to
8:22am
8-K
dm07w
11 Jun 19
Departure of Directors or Certain Officers
4:10pm
8-K
kc0exu a2se
4 Jun 19
Regulation FD Disclosure
7:00am
8-K
b5x6 cdw23bx
9 May 19
Akebia Therapeutics Reports First Quarter 2019 Financial Results; Announces Full
8:16am
8-K
hualva
18 Apr 19
Entry into a Material Definitive Agreement
7:50am
8-K
7pan6z3gr5f
10 Apr 19
Entry into a Material Definitive Agreement
7:35am
8-K
23of9fry
18 Mar 19
Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights
4:05pm